{"AllianceGenome": "609", "HGNC": "609", "MIM": "608083", "_id": "344", "_version": 1, "accession": {"genomic": ["AC011481.4", "AY422955.1", "CH471126.1", "CP068259.2", "FJ525875.1", "J02698.1", "M10612.1", "MT073872.1", "NC_000019.10", "NC_060943.1", "NG_008837.1", "X05151.1"], "protein": ["AAA51743.1", "AAA98743.1", "AAB59380.1", "AAD28193.1", "AAH05348.3", "AAH65270.1", "AAP35354.1", "AAQ91814.1", "ACN81313.1", "ALQ33366.1", "ALQ33367.1", "CAA25234.1", "CAA28798.1", "EAW57311.1", "EAW57312.1", "EAW57313.1", "NP_000474.2", "P02655.1", "QPM65715.1"], "rna": ["AA883870.1", "AF113884.1", "AV694494.1", "BC005348.2", "BC065270.1", "BT006708.1", "BU596546.1", "KU177908.1", "KU177909.1", "M29844.1", "NM_000483.5", "X00568.1"], "translation": [{"protein": "AAD28193.1", "rna": "AF113884.1"}, {"protein": "ALQ33367.1", "rna": "KU177909.1"}, {"protein": "CAA25234.1", "rna": "X00568.1"}, {"protein": "AAH05348.3", "rna": "BC005348.2"}, {"protein": "AAP35354.1", "rna": "BT006708.1"}, {"protein": "NP_000474.2", "rna": "NM_000483.5"}, {"protein": "ALQ33366.1", "rna": "KU177908.1"}, {"protein": "AAA51743.1", "rna": "M29844.1"}, {"protein": "AAH65270.1", "rna": "BC065270.1"}]}, "alias": ["APO-CII", "APOC-II"], "ensembl": {"gene": "ENSG00000234906", "protein": ["ENSP00000252490", "ENSP00000465001", "ENSP00000466775", "ENSP00000476835", "ENSP00000477261"], "transcript": ["ENST00000252490", "ENST00000585786", "ENST00000590360", "ENST00000591597", "ENST00000592257"], "translation": [{"protein": "ENSP00000477261", "rna": "ENST00000592257"}, {"protein": "ENSP00000252490", "rna": "ENST00000252490"}, {"protein": "ENSP00000476835", "rna": "ENST00000591597"}, {"protein": "ENSP00000466775", "rna": "ENST00000590360"}, {"protein": "ENSP00000465001", "rna": "ENST00000585786"}], "type_of_gene": "protein_coding"}, "entrezgene": "344", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 5.103756036, "exp_mis": 28.7462427917, "exp_syn": 15.3712079669, "lof_z": 0.922444217052617, "mis_z": 0.0680776370869656, "mu_lof": 3.51736667567e-07, "mu_mis": 2.52339894254e-06, "mu_syn": 1.28762018418e-06, "n_lof": 3.0, "n_mis": 28.0, "n_syn": 14.0, "p_li": 0.0227961322934307, "p_null": 0.211440005707994, "p_rec": 0.765763861998575, "syn_z": 0.216820050002316}, "bp": 306, "cds_end": 45452506, "cds_start": 45451735, "n_exons": 3, "nonpsych": {"exp_lof": 4.56053162093, "exp_mis": 25.9592642605, "exp_syn": 13.8535643169, "lof_z": 0.717656835409256, "mis_z": 0.0949624356341306, "mu_lof": 3.51736667567e-07, "mu_mis": 2.52339894254e-06, "mu_syn": 1.28762018418e-06, "n_lof": 3.0, "n_mis": 25.0, "n_syn": 13.0, "p_li": 0.0198932725554267, "p_null": 0.265208435921506, "p_rec": 0.714898291523067, "syn_z": 0.144383264805977}, "nontcga": {"exp_lof": 4.68971840988, "exp_mis": 26.4408079471, "exp_syn": 14.1357726044, "lof_z": 0.769701281087361, "mis_z": 0.0427092371665409, "mu_lof": 3.51736667567e-07, "mu_mis": 2.52339894254e-06, "mu_syn": 1.28762018418e-06, "n_lof": 3.0, "n_mis": 26.0, "n_syn": 14.0, "p_li": 0.0196564700726088, "p_null": 0.240245416712459, "p_rec": 0.740098113214933, "syn_z": 0.0228647481932381}, "transcript": "ENST00000590360.1"}, "exons": [{"cdsend": 44949249, "cdsstart": 44948478, "chr": "19", "position": [[44946050, 44946075], [44948465, 44948533], [44948700, 44948860], [44949158, 44949565]], "strand": 1, "transcript": "NM_000483", "txend": 44949565, "txstart": 44946050}], "exons_hg19": [{"cdsend": 45452506, "cdsstart": 45451735, "chr": "19", "position": [[45449307, 45449332], [45451722, 45451790], [45451957, 45452117], [45452415, 45452822]], "strand": 1, "transcript": "NM_000483", "txend": 45452822, "txstart": 45449307}], "generif": [{"pubmed": 8530039, "text": "Includes the observation of APOC4-APOC2 read-through transcription"}, {"pubmed": 11751863, "text": "Human apolipoprotein C-II (apoC-II) slowly forms amyloid fibers in lipid-free solutions at physiological pH and salt concentrations"}, {"pubmed": 11930616, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 12032151, "text": "regulated expression of gene cluster in macrophages"}, {"pubmed": 12220441, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 12450397, "text": "During amyloidosis under oxidizing conditions, cysteine-containing apolipoprotein C-II (apoC-II) derivatives form fibrils more rapidly and become extensively tangled compared to wild-type apoC-II."}, {"pubmed": 12590574, "text": "Three categories of global constraints, together with the local classical NMR constraints, define the 3D structure of the apoCII-SDS micelle complex and give important clues toward a possible mechanism for the activation of lipoprotein lipase by apoCII."}, {"pubmed": 12682050, "text": "regions of lipoprotein lipase that are responsive to activation by apoC-II"}, {"pubmed": 12782148, "text": "Hydrolysis activated by APOC2 was faster compared with the LPL-mediated lipolysis of emulsion triolein.  The binding density of APOC2 was less for small emulsion surfaces than for large ones."}, {"pubmed": 14746139, "text": "Observational study of genotype prevalence. (HuGE Navigator)"}, {"pubmed": 15031287, "text": "This protein, a non-fibrillar component, causes soluble fibrils to condense into localized fibrillar aggregates with a greatly enhanced local density of fibril entanglements."}, {"pubmed": 15778093, "text": "Different levels of secreted apoC-II had little effect on LDL and HDL protein degradation by HepG2 cells. Compared to controls, cells under-expressing apoC-II showed a 160% higher capacity to selectively take up HDL-CE."}, {"pubmed": 16432277, "text": "Results show that purified human HDL and recombinant apolipoprotein A-I lipid particles bind directly to amyloid beta and apolipoprotein C-II amyloid fibrils."}, {"pubmed": 16459141, "text": "No relationship was found between ApoCII polymorphism and coronary disease in the Chinese Han population."}, {"pubmed": 16459141, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 16763159, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 17018885, "text": "Decrease of LPL activity in the heart, along with the inhibitory effects of excess apolipoprotein C-II, may contribute to the hypertriglyceridemia observed in apolipoprotein c-ii transgenic mice."}, {"pubmed": 17174330, "text": "Taken together these data demonstrate an interaction between antichymotrypsin and apolipoprotein C-II that accelerates fibrillogenesis and indicates a specific role for accessory proteins in protein aggregation."}, {"pubmed": 17222387, "text": "These results suggested that T-->A substitution at position -190 in the apoC-II gene promoter only partly affected transcriptional activity of the apoC-II promoter, leading to decrease of apoC-II expression in quantity."}, {"pubmed": 17429947, "text": "The ozone oxidation product of cholesterol, 3beta-hydroxy-5-oxo-5,6-secocholestan-6-al, rapidly promotes human apolipoprotein (apo) C-II amyloid fibril formation in vitro."}, {"pubmed": 17717288, "text": "Both common and rare DNA variants of APOC2 gene were found in 10% patients with severe hypertriglyceridemia"}, {"pubmed": 17855807, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18005990, "text": "Phospholipid interaction induces molecular-level polymorphism in APOC2 amyloid fibrils via alternative assembly pathways."}, {"pubmed": 18206908, "text": "The concentration-dependent kinetics of apolipoprotein C-II amyloid fibril formation and correlated this with the final size distribution of the fibrils determined by sedimentation velocity experiments, is studied."}, {"pubmed": 18660489, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18852267, "text": "lipids promote on-pathway intermediates of apoC-II fibril assembly and the accumulation of a discrete tetrameric intermediate depends on the molecular state of the lipid"}, {"pubmed": 19014618, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19034041, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19336370, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19336475, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19534808, "text": "No significant differences were found between the acute hypertriglyceridaemic pancreatitis cases and controls with severe hypertriglyceridaemia in terms of LPL activity and mass, hepatic lipase activity, CII and CIII mass, or apo E polymorphisms."}, {"pubmed": 19878569, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19948975, "text": "Observational study of gene-disease association, gene-gene interaction, gene-environment interaction, and genetic testing. (HuGE Navigator)"}, {"pubmed": 20031551, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20042600, "text": "Results describe the functional role of the secondary structure in the lipoprotein lipase-binding portion of apolipoprotein CII."}, {"pubmed": 20331378, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20430392, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20498921, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20498921, "text": "This study examines the association between APOE/C1/C4/C2 gene cluster variation using tagging single nucleotide polymorphisms and plasma lipid concentration along with risk of coronary heart disease in a prospective cohort."}, {"pubmed": 20571754, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20634891, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20714348, "text": "Meta-analysis and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20864672, "text": "Observational study, meta-analysis, and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20972250, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21146539, "text": "Our structural model for apoC-II fibrils suggests that apoC-II monomers fold and self-assemble to form a stable cross-beta-scaffold containing relatively unstructured connecting loops."}, {"pubmed": 21321243, "text": "These results support a predictive change in the ratio of plasma ApoCIII to ApoCII in pregnancies complicated by severe preeclampsia."}, {"pubmed": 21476595, "text": "Physiological shear flow conditions and conditions experienced during apoC-II manufacturing exert significant effects on apoC-II conformation, leading to protein misfolding, aggregation, and amyloid fibril formation."}, {"pubmed": 21943158, "text": "variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits"}, {"pubmed": 21985034, "text": "Activation of apoC-II fibrils by submicellar lipid (NBD-lyso-12-phosphocholine) is catalytic with release of monomer- and tetramer-bound lipid accompanying fibril elongation and growth."}, {"pubmed": 22239554, "text": "Mutations in GPIHBP1 are rare but the associated clinical phenotype of hypertriglyceridaemia is severe"}, {"pubmed": 22244853, "text": "Substoichiometric concentrations of cyc[60-70] significantly delayed fibril formation by the fibrillogenic, linear peptides apoC-II[60-70] and apoC-II[56-76]."}, {"pubmed": 22808166, "text": "STAT1 bound on multienhancer 2 cooperates with RXRalpha located on apoCII promoter and upregulates apoCII expression only in macrophages."}, {"pubmed": 23631828, "text": "Six apolipoproteins (APOA1, APOA2, APOB, APOC2, APOC3, and APOE) were able to differentiate bladder cancer from hernia. SAA4 was significantly increased in bladder cancer subgroups, whereas ProEGF was significantly decreased in bladder cancer subgroups."}, {"pubmed": 25131724, "text": "No APOC2 mutations were identified in a cohort of patients with diabetic lipemia."}, {"pubmed": 25172036, "text": "Large deletion in APOC2 caused by Alu-Alu homologous recombination is associated with with apolipoprotein C-II deficiency."}, {"pubmed": 26026161, "text": "Conformational rearrangement of apoC-II at lipoprotein surfaces promotes interaction with LPL."}, {"pubmed": 26196342, "text": "The results highlight the importance of charge-pair interactions within the apoC-II fibril core"}, {"pubmed": 28229588, "text": "The results demonstrate the important role of both intra- and inter-subunit charge interactions in stabilizing apoC-II amyloid fibrils, a process that may be a key factor in determining the general ability of proteins to form amyloid fibrils."}, {"pubmed": 28534127, "text": "Triglyceride-raising variant alleles of the APOC2 encoding apo C-II, associated with clinical Cardiovascular endpoints."}, {"pubmed": 29371683, "text": "Results from this exploratory analysis suggest that regulatory element methylation levels within the larger TOMM40-APOE-APOC2 gene region correlate with AD-related biomarkers and TOMM40 or APOE gene expression in AD."}, {"pubmed": 29791776, "text": "The effect of apolipoprotein C2 K30D-D69K mutations on rod-like apolipoprotein C2 fibril formation."}, {"pubmed": 30686043, "text": "A case of patient with hereditary systemic amyloidosis caused by K19T apolipoprotein C-II variant is described."}, {"pubmed": 31133485, "text": "Reduced serum levels apolipoprotein A2 and apolipoprotein C2 were significantly associated with the presence of aneurysm wall enhancement in MRI angiography."}, {"pubmed": 31935511, "text": "Blood miR-1275 levels were negatively associated with the occurrence of Ischemic stroke (IS), and miR-1275 might exert an athero-protective role against the development of IS by targeting ApoC2 and blocking the formation of macrophage foam cells."}, {"pubmed": 31975384, "text": "miR-4510 acts as a tumor suppressor in gastrointestinal stromal tumor by targeting APOC2."}, {"pubmed": 32205061, "text": "Successful management of acute pancreatitis due to apolipoprotein C-II deficiency in a 37-day-old infant."}, {"pubmed": 32332429, "text": "Apolipoprotein C-II: the re-emergence of a forgotten factor."}, {"pubmed": 32332431, "text": "Regulation of lipoprotein lipase-mediated lipolysis of triglycerides."}, {"pubmed": 32944714, "text": "Apolipoprotein C2 - CD36 Promotes Leukemia Growth and Presents a Targetable Axis in Acute Myeloid Leukemia."}, {"pubmed": 33934596, "text": "Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the larger HDL3 from very low-density lipoprotein (VLDL)."}, {"pubmed": 34185418, "text": "Deregulation of apolipoprotein C2 gene in cancer: A potential metabolic vulnerability."}, {"pubmed": 34459127, "text": "Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K/AKT/mTOR pathway."}, {"pubmed": 34556808, "text": "Plasma apolipopotein C-2 elevation is associated with Takayasu arteritis."}, {"pubmed": 34921821, "text": "Association of the lipoprotein lipase and Apolipoprotein C-II gene polymorphisms with risk of dyslipidemia in smokers and non-smokers male."}, {"pubmed": 35820705, "text": "ScRNA-seq expression of IFI27 and APOC2 identifies four alveolar macrophage superclusters in healthy BALF."}, {"pubmed": 37094117, "text": "Inverse effects of APOC2 and ANGPTL4 on the conformational dynamics of lid-anchoring structures in lipoprotein lipase."}, {"pubmed": 37155355, "text": "Inverse association between apolipoprotein C-II and cardiovascular mortality: role of lipoprotein lipase activity modulation."}, {"pubmed": 38003484, "text": "Sequence Variant Analysis of the APOCII Locus among an Arab Cohort."}], "genomic_pos": {"chr": "19", "end": 44949565, "ensemblgene": "ENSG00000234906", "start": 44946035, "strand": 1}, "genomic_pos_hg19": [{"chr": "19", "end": 45452822, "start": 45445495, "strand": 1}, {"chr": "19", "end": 45452822, "start": 45449243, "strand": 1}], "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0010518", "qualifier": "involved_in", "term": "positive regulation of phospholipase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010518", "pubmed": 10727238, "qualifier": "involved_in", "term": "positive regulation of phospholipase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010898", "pubmed": 10727238, "qualifier": "involved_in", "term": "positive regulation of triglyceride catabolic process"}, {"evidence": "IC", "gocategory": "BP", "id": "GO:0010902", "pubmed": 10727238, "qualifier": "involved_in", "term": "positive regulation of very-low-density lipoprotein particle remodeling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0010916", "pubmed": 1917954, "qualifier": "involved_in", "term": "negative regulation of very-low-density lipoprotein particle clearance"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0016042", "qualifier": "involved_in", "term": "lipid catabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0032375", "pubmed": 15778093, "qualifier": "involved_in", "term": "negative regulation of cholesterol transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0033344", "pubmed": 11162594, "qualifier": "involved_in", "term": "cholesterol efflux"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0033700", "pubmed": 11162594, "qualifier": "involved_in", "term": "phospholipid efflux"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0034370", "pubmed": 17018885, "qualifier": "involved_in", "term": "triglyceride-rich lipoprotein particle remodeling"}, {"evidence": "IC", "gocategory": "BP", "id": "GO:0034371", "pubmed": 10727238, "qualifier": "involved_in", "term": "chylomicron remodeling"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0034372", "pubmed": 15778093, "qualifier": "involved_in", "term": "very-low-density lipoprotein particle remodeling"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0034382", "pubmed": 4020294, "qualifier": "involved_in", "term": "chylomicron remnant clearance"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0034384", "pubmed": 15778093, "qualifier": "involved_in", "term": "high-density lipoprotein particle clearance"}, {"evidence": "IC", "gocategory": "BP", "id": "GO:0042632", "pubmed": 15778093, "qualifier": "involved_in", "term": "cholesterol homeostasis"}, {"evidence": "IC", "gocategory": "BP", "id": "GO:0043691", "pubmed": 15778093, "qualifier": "involved_in", "term": "reverse cholesterol transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045723", "pubmed": 10727238, "qualifier": "involved_in", "term": "positive regulation of fatty acid biosynthetic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0045833", "pubmed": 182536, "qualifier": "involved_in", "term": "negative regulation of lipid metabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0048261", "pubmed": 1917954, "qualifier": "involved_in", "term": "negative regulation of receptor-mediated endocytosis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0051006", "qualifier": "involved_in", "term": "positive regulation of lipoprotein lipase activity"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0051006", "pubmed": [10727238, 15878877], "qualifier": "involved_in", "term": "positive regulation of lipoprotein lipase activity"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0060697", "qualifier": "involved_in", "term": "positive regulation of phospholipid catabolic process"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0060697", "pubmed": 10727238, "qualifier": "involved_in", "term": "positive regulation of phospholipid catabolic process"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0070328", "pubmed": 17018885, "qualifier": "involved_in", "term": "triglyceride homeostasis"}], "CC": [{"evidence": "NAS", "gocategory": "CC", "id": "GO:0005576", "pubmed": 14718574, "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005576", "qualifier": "located_in", "term": "extracellular region"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005615", "pubmed": 10727238, "qualifier": "located_in", "term": "extracellular space"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005769", "qualifier": "located_in", "term": "early endosome"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0034361", "pubmed": 8245722, "qualifier": "part_of", "term": "very-low-density lipoprotein particle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0034362", "pubmed": 8245722, "qualifier": "part_of", "term": "low-density lipoprotein particle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0034363", "pubmed": 17336988, "qualifier": "part_of", "term": "intermediate-density lipoprotein particle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0034366", "pubmed": 16682745, "qualifier": "part_of", "term": "spherical high-density lipoprotein particle"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0042627", "qualifier": "part_of", "term": "chylomicron"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0042627", "pubmed": 8245722, "qualifier": "part_of", "term": "chylomicron"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 32296183, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008289", "pubmed": 10727238, "qualifier": "enables", "term": "lipid binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0016004", "qualifier": "enables", "term": "phospholipase activator activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016004", "pubmed": 10727238, "qualifier": "enables", "term": "phospholipase activator activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0043274", "qualifier": "enables", "term": "phospholipase binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0043274", "pubmed": 10727238, "qualifier": "enables", "term": "phospholipase binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0055102", "pubmed": 182536, "qualifier": "enables", "term": "lipase inhibitor activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0060230", "pubmed": [270715, 10727238], "qualifier": "enables", "term": "lipoprotein lipase activator activity"}, {"category": "MF", "evidence": "EXP", "id": "GO:0140677", "pubmed": 15209504, "qualifier": "enables", "term": "molecular function activator activity"}]}, "homologene": {"genes": [[9544, 718319], [9598, 744578], [9606, 344], [9615, 442969], [9913, 618039], [10090, 11813], [10116, 292697]], "id": 47928}, "interpro": [{"desc": "Apolipoprotein C-II", "id": "IPR008019", "short_desc": "Apo-CII"}, {"desc": "ApoC-II domain superfamily", "id": "IPR023121", "short_desc": "ApoC-II_dom_sf"}], "ipi": "IPI00021856", "map_location": "19q13.32", "name": "apolipoprotein C2", "other_names": "apolipoprotein C-II", "pantherdb": {"HGNC": "609", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "88054", "ortholog_type": "LDO", "panther_family": "PTHR16566", "taxid": 10090, "uniprot_kb": "Q05020"}, {"RGD": "2135", "ortholog_type": "LDO", "panther_family": "PTHR16566", "taxid": 10116, "uniprot_kb": "G3V8D4"}, {"ZFIN": "ZDB-GENE-030131-2168", "ortholog_type": "LDO", "panther_family": "PTHR16566", "taxid": 7955, "uniprot_kb": "A0A286YAE3"}], "uniprot_kb": "P02655"}, "pathway": {"kegg": {"id": "hsa04979", "name": "Cholesterol metabolism - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-174824", "name": "Plasma lipoprotein assembly, remodeling, and clearance"}, {"id": "R-HSA-174824", "name": "Plasma lipoprotein assembly, remodeling, and clearance"}, {"id": "R-HSA-196854", "name": "Metabolism of vitamins and cofactors"}, {"id": "R-HSA-196854", "name": "Metabolism of vitamins and cofactors"}, {"id": "R-HSA-2187338", "name": "Visual phototransduction"}, {"id": "R-HSA-2187338", "name": "Visual phototransduction"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-6806667", "name": "Metabolism of fat-soluble vitamins"}, {"id": "R-HSA-6806667", "name": "Metabolism of fat-soluble vitamins"}, {"id": "R-HSA-8963888", "name": "Chylomicron assembly"}, {"id": "R-HSA-8963889", "name": "Assembly of active LPL and LIPC lipase complexes"}, {"id": "R-HSA-8963898", "name": "Plasma lipoprotein assembly"}, {"id": "R-HSA-8963899", "name": "Plasma lipoprotein remodeling"}, {"id": "R-HSA-8963899", "name": "Plasma lipoprotein remodeling"}, {"id": "R-HSA-8963901", "name": "Chylomicron remodeling"}, {"id": "R-HSA-8964058", "name": "HDL remodeling"}, {"id": "R-HSA-9006931", "name": "Signaling by Nuclear Receptors"}, {"id": "R-HSA-9024446", "name": "NR1H2 and NR1H3-mediated signaling"}, {"id": "R-HSA-9029569", "name": "NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux"}, {"id": "R-HSA-9709957", "name": "Sensory Perception"}, {"id": "R-HSA-9709957", "name": "Sensory Perception"}, {"id": "R-HSA-975634", "name": "Retinoid metabolism and transport"}, {"id": "R-HSA-975634", "name": "Retinoid metabolism and transport"}], "wikipathways": [{"id": "WP3584", "name": "MECP2 and Associated Rett Syndrome"}, {"id": "WP430", "name": "Statin inhibition of cholesterol production"}]}, "pdb": ["1BY6", "1I5J", "1O8T", "1SOH"], "pfam": "PF05355", "pharmgkb": "PA52", "pharos": {"target_id": 7911, "tdl": "Tbio"}, "pir": "A24238", "reagent": {"CM-LibrX-no-seq": [{"id": "GNF325265", "relationship": "is"}, {"id": "GNF325266", "relationship": "is"}], "CondMedia_CM_LibrAB": {"id": "GNF292686", "relationship": "is"}, "GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF245855", "relationship": "is"}, {"id": "GNF245856", "relationship": "is"}, {"id": "GNF245857", "relationship": "is"}, {"id": "GNF245858", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF160459", "relationship": "is"}, "GNF_hs-Origene": {"id": "GNF039228", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF079642", "relationship": "is"}, {"id": "GNF079643", "relationship": "is"}, {"id": "GNF079644", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054495", "relationship": "is"}, {"id": "GNF059272", "relationship": "is"}, {"id": "GNF074640", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070049", "relationship": "is"}, {"id": "GNF070050", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF000604", "relationship": "is"}, {"id": "GNF000605", "relationship": "is"}], "GNF_mm+hs_RetroCDNA": {"id": "GNF240236", "relationship": "is"}, "MasterSecretomicsList": [{"id": "GNF330877", "relationship": "is"}, {"id": "GNF334035", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF337237", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF114864", "relationship": "is"}, {"id": "GNF154505", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000019.10", "NC_060943.1", "NG_008837.1"], "protein": "NP_000474.2", "rna": "NM_000483.5", "translation": {"protein": "NP_000474.2", "rna": "NM_000483.5"}}, "reporter": {"HG-U133_Plus_2": ["204561_x_at", "206738_at", "231561_s_at", "231562_at"], "HG-U95Av2": ["34454_r_at", "36657_at"], "HTA-2_0": ["TC19002642.hg.1", "TC19002643.hg.1"], "HuEx-1_0": ["3835911", "3835921", "3835923"], "HuGene-1_1": ["8029541", "8029547", "8029551"], "HuGene-2_1": "16863138"}, "summary": "This gene encodes a lipid-binding protein belonging to the apolipoprotein gene family. The protein is secreted in plasma where it is a component of very low density lipoprotein. This protein activates the enzyme lipoprotein lipase, which hydrolyzes triglycerides and thus provides free fatty acids for cells. Mutations in this gene cause hyperlipoproteinemia type IB, characterized by hypertriglyceridemia, xanthomas, and increased risk of pancreatitis and early atherosclerosis. This gene is present in a cluster with other related apolipoprotein genes on chromosome 19. Naturally occurring read-through transcription exists between this gene and the neighboring upstream apolipoprotein C-IV (APOC4) gene. [provided by RefSeq, Mar 2011].", "symbol": "APOC2", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1412477"}, "unigene": "Hs.75615", "uniprot": {"Swiss-Prot": "P02655", "TrEMBL": ["Q6P163", "A0A024R0T9", "V9GYJ8", "V9GZ01"]}, "wikipedia": {"url_stub": "Apolipoprotein C2"}}